64
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Diagnostic performance of plasma high sensitive C‐reactive protein in detecting three‐vessel coronary artery disease: modification by apolipoprotein E genotype

, , , , , & show all
Pages 714-719 | Received 22 Feb 2008, Accepted 25 Apr 2008, Published online: 08 Jul 2009

References

  • Mazer S. P., Rabbani L. R. E. Evidence for C‐reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno‐regulation and CRP. J Thromb Thrombolysis 2004; 17: 95–105
  • Ridker P. M. Clinical application of C‐reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363–9
  • Zwaka T. P., Hombac V., Torzewski J. C‐reactive protein‐mediated low density lipoprotein uptake by macrophages. Implications for atherosclerosis. Circulation 2001; 103: 1194–7
  • Woollard K. J., Phillips D. C., Griffiths H. R. Direct modulatory effect of C‐reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 2002; 130: 256–62
  • Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–30
  • März W., Scharnagl H., Hoffmann M. M., Boehm B. O., Winkelmann B. R. The apolipoprotein E polymorphism is associated with circulating C‐reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 2004; 25: 2109–19
  • Austin M. A., Zhang C., Humphries S. E., Chandler W. L., Talmud P. J., Edwards K. L., et al. Heritability of C‐reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 2004; 68: 179–88
  • Ilveskoski E., Perola M., Lehtimäki T., Laippala P., Savolainen V., Pajarinen J., et al. Age‐dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle‐aged men. An autopsy study. Circulation 1999; 100: 608–13
  • Lehtimäki T., Hervonen A., Rontu R., Karhunen P., Jylhä M., Hurme M. Survival related to plasma C‐reactive‐protein in nonagenarians is modified by apolipoprotein E genotype. Clin Chem 2007; 53: 365–7
  • Eagle K. A., Guyton R. A., Davidoff R., Edwards F. H., Ewy G. A., Gardner T. J., et al. ACC/AHA 2004 guidelines update for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery). Circulation 2004; 110: 340–437
  • Judkins M. P. Selective coronary arteriography. Radiology 1967; 89: 815
  • Eda S., Kaufmann J., Roos W., Pohl S. Development of a new microparticle‐enhanced turbidimetric assay for C‐reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137–44
  • Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
  • Ridker P. M., Rifai N., Rose L., Buring J. E., Cook N. R. Comparison of C‐reactive protein and low‐density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557–65
  • Kardia S. L. R., Haviland M. B., Ferrell R. E., Sing C. F. The relationship between risk factor levels and presence of coronary artery calcification is dependent on Apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 1999; 19: 427–35
  • Chen Q., Reis S. E., Kammerer C. M., McNamara D. M., Holubkov R., Sharaf B. L., et al. APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. Atherosclerosis 2003; 169: 159–67
  • Lahoz C., Schaefer E. J., Cupples A., Wilson P. W. F., Levy D., Osgood D., et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001; 154: 529–37
  • Judson R., Brain C., Dain B., Windemuth A., Ruano G., Reed C. New and confirmatory evidence of an association between APOE genotype and baseline C‐reactive protein in dyslipidemic individuals. Atherosclerosis 2004; 177: 345–51
  • Paul A., Ko K. W. S., Li L., Yechoor V., McCrory M. A., Szalai A. J., et al. C‐reactive protein accelerates the progression of atherosclerosis in Apolipoprotein E‐deficient mice. Circulation 2004; 109: 647–55
  • Torzewski M., Rist C., Mortensen R. F., Zwaka T. P., Bienek M., Waltenberger J., et al. C‐reactive protein in the arterial intima. Role of C‐reactive protein receptor‐dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 2094–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.